6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: November 4, 2022
Period of Report: November 4, 2022
Accession Number: 0001213900-22-069389

View Document ↗ View on SEC.gov ↗